Disorders of coagulation may occur after uncomplicated hepatic resection in patients who have normal preoperative coagulation profiles and liver function tests. We present a retrospective study performed in a tertiary care university teaching hospital examining changes in liver function tests and coagulation profiles in patients undergoing hepatic resection. Data were obtained for 124 patients. When compared to the preoperative values, prothrombin times were significantly increased throughout the postoperative period. Prolongation of the prothrombin time was related to both duration of surgery and hepatic resection weight. There was no relationship between prothrombin time and patient age. Disorders of coagulation occur after hepatic resection even in patients who have normal preoperative coagulation and liver function tests. This has implications for anaesthetic practice, particularly when considering the use of an indwelling epidural catheter in patients undergoing hepatic resection.
Partial hepatectomy is an established effective and potentially curative therapy for selected patients with benign and malignant hepatobiliary disease. Recently observed reductions in perioperative morbidity and mortality are attributable to improved patient selection, advances in operative and anaesthetic technique, and the evolution of hepatobiliary surgery as an area of specialization. Advances in the assessment and understanding of hepatic physiology and anatomy, and the application of anatomically based and parenchymal-sparing segmental resections, have been fundamental developments 1 . evidence suggests that disorders of coagulation may still occur after uncomplicated resection in patients who have normal preoperative coagulation profiles, even in the absence of massive transfusion [2] [3] [4] . This has implications for anaesthetic practice, particularly when considering the use of an indwelling epidural catheter for intraoperative anaesthesia and postoperative analgesia.
Coagulopathy increases the risk of bleeding complications associated with epidural techniques and may lead to potentially devastating sequelae including epidural haematoma and spinal cord compression. Although continuous epidural anaesthesia and analgesia is an accepted technique for patients undergoing major hepatic resection 2,5-8 , some institutions now consider the procedure to be unsafe 9, 10 . The aim of the current study was to examine changes in blood coagulation and hepatic function in patients undergoing hepatic resection and to investigate whether the duration of surgery, extent of the hepatic resection and patient age are predictors of postoperative coagulopathy.
MeTHoDS
A retrospective review was performed of the records of patients who underwent hepatic resection between 1998 and 2003 at Addenbrooke's nHS Trust, Cambridge, united Kingdom. one hundred and fortyfive hepatic resections were performed during this period. Trauma and paediatric patients and those with chronic liver disease or abnormal preoperative liver function and coagulation profiles were subsequently excluded. Therefore only data from patients with normal preoperative hepatic, coagulation and platelet profiles were analysed. Addenbrooke's Hospital is a tertiary referral centre affiliated with Cambridge university and has a dedicated Hepatobiliary Service and Liver Transplant unit. Without exception, all patients were offered an epidural catheter for postoperative analgesia. For patients who refused a regional technique, or when epidural insertion was not possible, intravenous morphine via a patient controlled analgesia (PCA) device was administered for postoperative analgesia. general anaesthesia was managed by a small group of specialist anaesthetists using a protocol designed to standardize patient care. Induction of anaesthesia was achieved using a balanced technique combining intravenous midazolam 0.02-0.03 mg/kg, fentanyl 1-2 µg/kg, propofol 1-3 mg/kg and atracurium 0.5 mg/kg. Anaesthesia was maintained with isoflurane or desflurane at inspired concentrations of 0.5-1.5 MAC, in a 50% oxygen-air balance, and an infusion of remifentanil 0.2-0.4 µg/kg/minute. Mechanical ventilation maintained endtidal PCo 2 between 35 and 40 mmHg. Routine monitoring included continuous electrocardiography, pulse oximetry, capnography, invasive arterial blood pressure, central venous pressure, urine output and core body temperature. Intraoperative normothermia was maintained with warm fluids (Medi-Temp II, gaymar Industries, nY, u.S.A.) and a forced-air warming device (WarmAir, Convective Air Therapy, Cincinnati Sub-zero, Connecticut, u.S.A.). During the prehepatic resection phase, the administration of fluids was reduced and central venous pressure was maintained at less than 6 mmHg for the duration of hepatic parenchymal resection. After hepatic resection, an infusion of warm fluids was administered to render patients euvolaemic. urine output was maintained at greater than 0.5 ml/kg/h, and systolic blood pressure was maintained within 20% of the preoperative value. At the end of surgery, patients with epidural catheters were managed by the administration of an epidural loading dose of local anaesthetic, followed by an infusion of bupivacaine 0.125% and fentanyl 2 µg/ml. Patients who had refused epidural analgesia where given an intravenous loading dose of morphine and were commenced on morphine PCA. The trachea was extubated and all patients were transferred to the post anaesthesia care unit. For the first postoperative night, patients were nursed in a high dependency unit under the care of on-call anaesthetic staff and then transferred to the surgical ward for ongoing care. Patients were monitored by a dedicated acute pain service and reviewed daily for any complications arising from their analgesic regimen. Patients were given intravenous vitamin K 10 mg daily for three days.
Data collected included patient demographics, type of operation performed, duration of surgery, hepatic resection weight and hepatic resection histology. Laboratory tests collected included platelet count, prothrombin time (PT) and liver function tests (LFTs). Laboratory values were recorded for seven consecutive days, or until hospital discharge. blood loss during surgery, intraoperative fluids and intraoperative blood products administered were not recorded. Standard descriptive statistics were used to calculate means and percentages. Changes in laboratory values were assessed by using analysis of variance for repeated measures and paired t tests. The P value was corrected for multiple testing using the bonferroni adjustment and only a P value of <0.007 was considered statistically significant. Variables such as hepatic resection weight, duration of surgery and patient age were investigated for possible correlation with changes in the PT and LFTs. Linear regression was initially performed and then multiple regression analyses were used to adjust for the other independent variables. Here a P value of <0.05 was considered statistically significant.
ReSuLTS
one hundred and twenty-four patients with normal preoperative clotting and hepatic function tests undergoing liver resection are presented. Demographic and clinical variables are presented in Table  1 . The changes in the platelet count, PT, and LFTs are presented in Table 2 . All preoperative coagulation values were within normal ranges. When compared to the preoperative values, PT was significantly increased throughout the postoperative period (P<0.001) ( Figure 1 ). on the third postoperative day, 43% of patients still had an elevated PT (Table 3) . Linear regression analyses revealed that prolongation of the PT was related to both duration of surgery (P<0.001 for Days 0 to 7, R 2 =0.21 on the second postoperative day) and hepatic resection weight (P<0.01 on Days 0 to 5, P<0.05 on Day 6, R 2 =0.30 on the second postoperative day) (Figures 2 and 3 ). There was no association between PT and patient age. Multiple regression analyses showed that when duration of surgery was adjusted for hepatic resection weight, both variables remained significant indicators of changes in PT (P<0.001).
All preoperative LFTs were within normal ranges. Alanine transaminase levels peaked on the first postoperative day (mean 261±187.3 Iu/l). bilirubin levels peaked on the third postoperative day (mean 36±29.5 µmol/l). Alkaline phosphatase levels remained slightly elevated throughout the postoperative period. These changes were not clinically significant. There were two patients with significant thrombocytopaenia. one patient had a platelet count of less than 50×10 9 /l immediately postoperatively. This had returned to normal by the following day. Another patient had platelet counts of 39×10 9 /l and 23×10 9 /l, on Days 6 and 7 respectively. The cause and treatment of these low platelet counts was not recorded.
DISCuSSIon established factors that contribute to the development of coagulopathy after hepatic resection include massive transfusion [11] [12] [13] underlying liver disease 14, 15 , blood loss 16 , the diluting effect of intraoperative infused fluids, the extent of hepatic resection 3, 6, 12, 14, 15, 17, 18 and transient postoperative synthetic insufficiency of the liver remnant 19 . This study adds to the body of evidence supporting the occurrence of significant changes in coagulation following hepatic resection, even in low risk patients who have normal preoperative coagulation and liver function profiles. This study demonstrates that maximal disturbances in the PT occur on the first and second postoperative days. both hepatic resection weight and duration of surgery are significantly related to the changes in disturbances in PT. Importantly, significant derangements in PT occurred throughout the postoperative period. over 70% of patients had a significantly elevated PT on Day 1. This remained elevated in more than 40% of patients on Day 3, with 7% of patients having a PT above 20 seconds. even by the seventh postoperative day, 22% of patients still had an elevated PT. These results have considerable implications for anaesthetic practice, particularly when considering the techniques available for providing postoperative analgesia.
There have been no systematic reviews comparing the efficacy of varying analgesic regimens for patients undergoing hepatic resection. The anaesthetist faces the dilemma that the administration of systemic opioids may lead to excessive sedation and risk of encephalopathy, whereas coagulopathy increases the risk of bleeding complications associated with regional analgesic techniques and possible devastating sequelae of epidural haematoma and spinal cord compression 18 . If an epidural infusion is not used to provide postoperative analgesia, then other drugs or methods will need to be used to provide suitable postoperative analgesia. Patient controlled analgesia with intravenous morphine, used in combination with regular paracetamol, is an example of an alternative regimen. other regional analgesic options include the use of field infiltration, intercostal nerve blocks, and interpleural catheters, all of which may have opioidsparing effects.
In this study, there were no major complications associated with epidural insertion, manipulation or removal. However, given that serious adverse complications such as epidural haematoma and paraplegia from catheter insertion and removal are rare, the small sample size requires cautious interpretation in regards to the safety of this technique. epidural haematoma typically occurs in patients with abnormal coagulation. Importantly, as many as 50% of epidural haematomas are associated with epidural removal 20, 21 . both catheter removal and the patient's coagulation at the time of removal are critical factors in the development of spinal haematoma 20 . given that this study demonstrates a significant postoperative prolongation of PT and a linear relationship between hepatic resection size, duration of surgery, and derangements in PT during the postoperative period, there is likely to be an increased risk of bleeding during catheter removal. A direct relationship between prolongation of the PT and the extent of the liver resection has also been confirmed in other studies 3, 6 . Currently, no single test can definitively and reliably predict the postoperative coagulopathy that occurs after hepatic resection. However, recent studies have shown that helical computed tomography or magnetic resonance imaging and newly designed software can assess resection extent by measurement of the anticipated volume of the liver remnant 22, 23 . Therefore, it may be prudent to avoid indwelling catheters if the expected hepatic resection is large (suggested by preoperative volumetric assessment) or if the duration of surgery will be prolonged (patient obesity or anatomical liver variants/abnormalities suspected with preoperative imaging). Discussion with the surgeon regarding complexity of the operative technique and estimated duration of surgery should form part of the pre-anaesthetic evaluation. The riskto-benefit ratio for each patient should be individually assessed, taking such factors into account.
Analgesic techniques utilizing an indwelling epidural catheter in patients undergoing hepatic resection should be managed with consideration to the postoperative changes in coagulation found in this study. The current guidelines for epidural catheter removal are well established for patients receiving anticoagulation for thromboprophylaxis 21, 24 . Little information is available on the timing of catheter removal for patients who have undergone major hepatic resection. In these patients, in addition to following the standard guidelines, it would be prudent to monitor the PT throughout the postoperative period and take this into account when manipulating or removing the epidural catheter.
In this study, intraoperative variables such as temperature, blood loss, transfusion requirements and the volume and type of infused fluid were not analysed, as they were not accurately recorded. In the postoperative period, use of coagulation factors was very much restricted to the treatment of bleeding complications. blood products were thus used sparingly and were not specifically recorded. Patients with abnormal pre-existing coagulation and LFT profiles, as well as trauma and paediatric patients, were also excluded. If we had included these patients, we would have confounded the results, limiting the validity of the study findings. The precise number of patients who received an epidural catheter was not recorded, in the knowledge that the study was never going to be sufficiently powered to comment on the safety of epidural analgesia for liver resection. However, we believe these limitations, together with the retrospective design, do not affect the value of the data or the conclusions. The study was designed to only identify the changes in coagulation in patients with normal preoperative clotting and hepatic profiles in order to better appreciate the magnitude of the changes in coagulation that occur following hepatic resection. The marked derangements in postoperative coagulation reinforce the need for vigilant clinical and laboratory monitoring for neurological and bleeding complications, particularly if neuraxial based techniques are being considered.
balancing the advantages of optimal analgesia against the risks associated with current techniques to achieve the greatest benefits requires a body of clinical trial evidence that does not yet exist 18 . given the known haemostatic derangements that occur, the question of whether the risks of epidural analgesia are justifiable in the management of pain for patients undergoing hepatic resection needs to be discussed. However, alternative analgesic options may be associated with different safety concerns and a poorer quality of postoperative analgesia. Prospective randomized trials are needed to compare both the effectiveness and safety of intravenous, interpleural and epidural analgesia in patients undergoing hepatic resection. A national liver resection management and perioperative outcomes database may help define the safety of neuraxial based techniques as well as determine effective multimodal alternatives 18 .
